Trinity Biotech (TRIB) Dividends Paid - Common Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Dividends Paid - Common Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.38% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 5.75% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 0.11% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | -16.01% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -599.76% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 9.77% |
| 10 | Trinity Biotech | 6.77 Mn | 1.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -41.58% |
| Dec 31, 2023 | -48.69% |
| Sep 30, 2023 | -32.00% |
| Dec 31, 2022 | -26.25% |
| Sep 30, 2022 | -33.88% |
| Mar 31, 2022 | -30.19% |
| Dec 31, 2021 | -5.06% |
| Sep 30, 2021 | -8.34% |
| Jun 30, 2021 | -16.65% |
| Mar 31, 2021 | -15.71% |
| Dec 31, 2020 | -22.01% |
| Sep 30, 2020 | -31.71% |
| Jun 30, 2020 | -37.57% |
| Mar 31, 2020 | -42.55% |
| Dec 31, 2019 | -40.31% |
| Sep 30, 2019 | -33.35% |
| Jun 30, 2019 | -33.49% |
| Mar 31, 2019 | -32.76% |
| Dec 31, 2018 | -33.28% |
| Sep 30, 2018 | 107.99% |